Location: Home
  • search
  • go
  • Relate News
  • 6/17/2021Roche Secures Chinese Approval of Evrysdi (Risdiplam) under Priority R...
  • 6/17/2021State Council Issues Document on Major Tasks of Healthcare Reform in 2...
  • 6/16/2021140 Low-Cost Supplementary Medical Insurance Plans Launched in 26 Prov...
  • 6/16/2021NMPA Announces Package Insert Revision of Carbimazole Tablets
  • 6/15/2021USFDA Approved IND to Investigate Combo of Asieris' APL-1202 and BeiGe...
  • 6/15/2021Over 6M People in Shanghai Enroll in Low-Cost Supplementary Health Ins...
  • 6/15/2021NHSA Publishes 2020 National BMI Sector Development Report
  • 6/15/2021NHSA Solicits Comments on the Healthcare Security Law of PRC
  • 6/15/2021NMPA and Chinese Customs Announce Addition of Changchun Airport as a D...
  • 6/14/2021AiPharma Signs Production and Distribution Deal for China and Russia w...
  • 6/14/2021I-Mab in Talks for a $Billion Deal for Cancer Therapy: Bloomberg
  • 6/11/2021Recent Executive Moves
  • 6/11/2021China Imposes $117M Fine for Resale Price Maintenance for the First T...
  • 6/10/2021PharmaDJ's China Market Approval Tracker: April 2021
  • 6/10/2021Hummingbird and Novogene Enter into Strategic Partnership for Anticanc...
  • 6/10/2021European Cos in China Navigate COVID-19 and More Perilous Waters Ahead...
  • 6/10/2021WuXi XDC and LegoChem Biosciences Signed MOU for Development and Manuf...
  • 6/10/2021Remegen Secures First Chinese Approval for Domestic ADC Product
  • 6/10/2021NHSA Solicits Comments on the Draft Interim Rules for Handling of Medi...
  • 6/10/2021NHSA Solicits Comments on the Working Plan and the Application Guide f...
  • 6/9/2021China to Initiate Full Implementation of the DRG and DIP Trials follow...
  • 6/8/2021IQVIA: Chinese Hospital Drug Market Soared 20.9% in Q1/2021
  • 6/8/2021Bio-Thera Moves Golimumab Biosimilar Candidate into Phase 3 Trial
  • 6/8/2021Is the Stage Set for Precision Medicine to Take Off in Asia?
  • 6/7/2021China Vows to Promote High-Quality Development of Public Hospitals (Up...
  • 6/7/2021BeiGene's Chinese sBLA for Tislelizumab in MSI-H or dMMR Solid Tumo...
  • 6/4/2021CDE Solicits Comments on the Technical Guidelines for MRD Detection in...
  • 6/4/2021Recent Executive Moves
  • 6/3/2021Stemirna Raises about $200M to Fund COVID-19 Vaccine Development
  • 6/3/2021Sesen Bio Announces Global Supply Partnership with Qilu Pharma
  • Page:92/360 Total number of articles:10791: [First][<<] [90] [91] [92] [93] [94] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group